- Business Wire•12 minutes agoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and Encourages Investors with Losses to Contact the Firm
Khang & Khang LLP announces the filing of a class action lawsuit against Taro Pharmaceutical Industries Ltd. . Investors, who purchased or otherwise acquired shares between July 3, 2014 and September 9, 2016 inclusive , are encouraged to contact the Firm before the December 27, 2016 lead plaintiff motion deadline.
- Business Wire•3 hours agoTARO SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Taro Pharmaceutical Industries Ltd. – TARO
Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 26, 2016 to file lead plaintiff applications in a securities class action lawsuit against Taro Pharmaceutical Industries Ltd.
- Business Wire•7 hours agoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and Encourages Investors with Losses to Contact the Firm
Lundin Law PC, a shareholder rights firm, announces a class action lawsuit has been filed against Taro Pharmaceutical Industries concerning possible violations of federal securities laws between July 3, 2014 and September 9, 2016 .
Taro Pharmaceutical Industries Ltd. (TARO)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||104.37 x 100|
|Ask||104.60 x 400|
|Day's Range||101.47 - 104.85|
|52wk Range||101.02 - 157.99|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||8.13|
|Avg Vol (3m)||238,226|
|Dividend & Yield||N/A (N/A)|